非酒精性脂肪性肝病患者的脾脏大小与肝病组织学分期无相关性
Spleen Size Does Not Correlate With Histological Stage of Liver Disease in People With Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-01-13
本研究观察非酒精性脂肪性肝病(NAFLD)患者脾脏大小与肝病组织学分期的关系,发现二者无相关性,而脾脏大小与体重、身高及血清高密度脂蛋白(HDL)水平呈强相关。
要点
- NAFLD患者脾脏大小与肝病组织学分期无相关性。
- 脾脏大小与体重、身高及血清HDL水平呈强相关。
- 脾大在NAFLD患者中不一定提示晚期肝病或门脉高压。
核心结论
- NAFLD患者脾脏大小与肝病组织学分期无相关性,而与体重、身高及血清HDL水平呈强相关。
研究设计与样本
- 观察性研究,研究对象为非酒精性脂肪性肝病(NAFLD)患者。
主要发现
- 脾脏大小与NAFLD组织学分期无相关性。
- 脾脏大小与体重、身高及血清高密度脂蛋白(HDL)水平呈强相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Splenomegaly in the context of liver disease is classically associated with advanced cirrhosis and portal hypertension.1 More recently, we observed an increasing number of patients with splenomegaly and nonalcoholic fatty liver disease (NAFLD), but in whom intensive work-up revealed no evidence of advanced liver disease or portal hypertension. In this study, we found no correlation between spleen size and histological stage of NAFLD, and a strong correlation between body weight, height and serum high density lipoprotein (HDL) levels.
来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。
引用
- Cacciottolo TM, Kumar A, Godfrey EM, et al. Spleen Size Does Not Correlate With Histological Stage of Liver Disease in People With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2022. PMID: 35032633. doi:10.1016/j.cgh.2022.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。